What is Organizing Pneumonia?
Organizing pneumonia (OP) is a specific pattern of lung injury characterized by plugs of granulation tissue (fibroblasts and myofibroblasts in loose connective matrix) filling the alveolar ducts and alveoli, with or without bronchiolar involvement, representing a reversible inflammatory response rather than true infection. 1, 2
Definition and Classification
Organizing pneumonia is classified as an interstitial lung disease and represents a histopathologic pattern rather than a single disease entity 3. The term "organizing pneumonia" has replaced the older terminology "bronchiolitis obliterans organizing pneumonia (BOOP)" 4, 5.
Two main categories exist:
- Cryptogenic Organizing Pneumonia (COP): Idiopathic form when no underlying cause is identified, accounting for approximately 5-10% of idiopathic interstitial pneumonias 1, 6
- Secondary Organizing Pneumonia (SOP): Associated with identifiable causes including:
Clinical Presentation
Patients typically present with a subacute illness of relatively short duration (median less than 3 months) following a flu-like prodrome 1, 5. Key features include:
- Respiratory symptoms: Dry cough and progressive dyspnea 6
- Constitutional symptoms: Fever, fatigue, and weight loss are common 5, 6
- Physical examination: May be normal or reveal inspiratory crackles 5
- Hypoxemia: Can occur at rest or with exertion 5
- Age: Average diagnosis between 50-60 years 6
Radiologic Features
HRCT characteristically demonstrates patchy and often migratory consolidation in a subpleural, peribronchial, or bandlike pattern, commonly associated with ground-glass opacity 1.
Three main imaging patterns exist:
- Typical pattern: Multiple patchy alveolar opacities (most common) 2
- Focal pattern: Solitary nodule or mass 2
- Diffuse pattern: Diffuse infiltrative opacities 2
Specific helpful radiologic signs include:
- Perilobular opacities 1
- Reversed halo sign (atoll sign) - a central ground-glass opacity surrounded by denser consolidation 1, 2
- Small unilateral or bilateral pleural effusions (10-30% of patients) 1
- Localized consolidations typically subpleural or in lower zones 6
Histopathology
The defining histologic feature is patchy filling of alveolar ducts and alveoli by loose plugs of connective tissue (buds of granulation tissue) 2, 9. The process results from a sequence of alveolar injury, fibrin deposition, and colonization by proliferating fibroblasts 2. Some cases show marked interstitial inflammation overlapping with cellular nonspecific interstitial pneumonia (NSIP) 1.
Prognosis and Treatment Response
The majority of patients recover completely with oral corticosteroids, which is a defining feature of the disease 1, 5. However, several important caveats exist:
- Relapse is common (25-50%), typically occurring during steroid taper or after withdrawal 1, 5
- Prolonged corticosteroid courses (6-12 months) are recommended 5
- A minority of patients develop progressive interstitial fibrosis despite treatment, with residual or recurrent episodes 1
- Prognosis in COP is generally excellent; in SOP it depends on the underlying cause 9
Critical Diagnostic Distinction
A crucial clinical point: OP requires corticosteroids, not antimicrobials 3. This is particularly important in post-COVID-19 patients with atypical chest imaging, where OP should be considered as a complication rather than bacterial superinfection 3, 7.
The fundamental challenge in understanding OP lies in differentiating this reversible process from irreversible fibrosis (as seen in usual interstitial pneumonia/IPF), as this distinction determines vastly different outcomes 2.